skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
Mesothelioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine (Code C78448)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Mesothelioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine

Definition: A cell-based cancer vaccine consisting of autologous dendritic cells (DCs) pulsed with mesothelioma tumor lysate with potential immunostimulating and antineoplastic activities. Upon administration, mesothelioma tumor lysate-pulsed autologous dendritic cell vaccine may stimulate the host immune system to mount a specific cytotoxic T lymphocyte (CTL) response against mesothelioma tumor cells, resulting in tumor cell lysis.

Label: Mesothelioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine

NCI Thesaurus Code: C78448 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: CL387563  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Mesothelioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine

External Source Codes: 
PDQ Closed Trial Search ID 599454
PDQ Open Trial Search ID 599454 (check for NCI PDQ open clinical trial info)
NCI META CUI CL387563

Other Properties:
     Name Value (qualifiers indented underneath)
code C78448
Legacy_Concept_Name Mesothelioma_Tumor_Lysate-Pulsed_Autologous_Dendritic_Cell_Vaccine
Semantic_Type Cell
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  

URL: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C78448

Mainbox Bottom